• Home
  • About
  • Investors
  • Science
  • Announcements
cardiogeni.com

Update on Conditional Share Exchange Agreement

by Darrin Disley | Apr 1, 2026 | Uncategorized

1st April 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin...

Cardiogeni Plc – Conditional Share Exchange Agreement

by Darrin Disley | Mar 16, 2026 | Uncategorized

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”). IN ADDITION,...

Cardiogeni Plc – Results of Annual General Meeting

by ollie@ojtdigital.com | Dec 31, 2025 | Uncategorized

Cardiogeni PLC – Result of Annual General Meeting RNS Number : 3445N Cardiogeni PLC 31 December 2025 31 December 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Results of Annual General Meeting Cardiogeni (AQSE: CGNI),...

Cardiogeni PLC – Interim Results

by ollie@ojtdigital.com | Dec 29, 2025 | Uncategorized

Cardiogeni PLC – Interim Results RNS Number : 8517M Cardiogeni PLC 29th December 2025 Cardiogeni plc (“Cardiogeni” or the “Company”) Interim Results – Period April 1st 2025 to 30th September 2025 Cardiogeni plc (AQSE:...

Cardiogeni PLC – Notice of Annual General Meeting

by ollie@ojtdigital.com | Dec 8, 2025 | Uncategorized

Cardiogeni PLC – Notice of Annual General Meeting RNS Number : 6987K Cardiogeni PLC 08 December 2025 8 December 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Notice of Annual General Meeting Cardiogeni (AQSE: CGNI),...

Cardiogeni PLC – Restatement of Financial Statements

by ollie@ojtdigital.com | Oct 10, 2025 | Uncategorized

Cardiogeni PLC – Restatement of Financial Statements RNS Number : 6584E Cardiogeni PLC 24 October 2025 24 October 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Cardiogeni Announces Restatement of Financial Statements for the Year...
« Older Entries
Next Entries »
Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

  • Home
  • About
  • Investors
  • Science
  • Announcements

Socials

  • Follow

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: